Top Suppliers:I want be here

141699-55-0

141699-55-0 structure
141699-55-0 structure

Name 1-Boc-3-hydroxyazetidine
Synonyms 1-TERT-BUTOXYCBONYL-3-HYDROXYAZETIDINE
MFCD04115305
1-(TERT-BUTOXYCBONYL)-3-HYDROXYAZETIDINE
1-TERT-BUTOXYCBONYL-3-AZETIDINOL
1-Boc-azetidin-3-ol
N-Boc-3-Azetidinol
1-BOC-3-Hydroxyazetidine
1-N-Boc-3-hydroxyazetidine ISO 9001:2015 REACH
1-Azetidinecboxylic acid, 3-hydroxy-, 1,1-dimethylethyl ester
3-HYDROXYAZETIDINE, N-BOC PROTECTED
TERT-BUTYL 3-HYDROXYAZETIDINE-1-CBOXYLATE
1-(tert-Butoxycarbonyl)-3-hydroxyazetidine
tert-butyl 3-hydro×yazetidine-1-cbo×ylate
1-Boc-3-(Hydroxy)azetidine
tert-Butyl 3-hydroxyazetidine-1-cboxylate, 1-(tert-Butoxycbonyl)-3-hydroxyazetidine
1-(tert-Butoxycbonyl)-3-hydroxyazetidine >
cbamate Q092 RSM2)
1-Boc-3-hydroxyazetidine tert-Butyl 3-Hydroxyazetidine-1-cboxylate 3-Hydroxyazetidine-1-cboxylic Acid tert-Butyl Ester
3-HYDROXY-AZETIDINE-1-CBOXYLIC ACID TERT-BUTYL ESTER
1-N-Boc-3-hydroxyl-azetidine
BUTTPK 75
N-BOC-3-HYDROXYAZETIDINE
J-141699
1-tert-Butoxycbonyl-3-azetidinol tert-butyl 3-hydroxyazetidine-1-cboxylate 1-BOC-3-(HYDROXY)AZETIDINE 1-(tert-Butoxycbonyl)-3-azetidinol
Bicitinib-012
N-Boc-3-hydroxyazetidine
1-azetidinecboxylic acid, 3-hydroxy-, 1,1-dimethylethyl
3-hydroxy-1-azetidinecboxylic acid tert-butyl ester
1-N-BOC-3-HYDROXYAZETIDINE
tert-butyl-3-hydroxyazetidine-4-cboxylate
tert-Butyl 3-Hydroxyazetidine-1-carboxylate
3-Hydroxyazetidine-1-carboxylic Acid tert-Butyl Ester
N-Boc-Azetidin-3-ol
Description 1-N-Boc-3-hydroxyazetidine is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). 1-N-Boc-3-hydroxyazetidine is also a alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs
Related Catalog
Target

Non-cleavable

In Vitro ADCs are comprised of an antibody to which is attached an ADC cytotoxin through an ADC linker[1]. PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins[2].
References

[1]. Beck A, et al. Strategies and challenges for the next generation of antibody-drug conjugates. Nat Rev Drug Discov. 2017;16(5):315-337.

[2]. Nalawansha DA, et al. PROTACs: An Emerging Therapeutic Modality in Precision Medicine. Cell Chem Biol. 2020;27(8):998-985.

Density 1.2±0.1 g/cm3
Boiling Point 253.7±33.0 °C at 760 mmHg
Melting Point 42-44°C
Molecular Formula C8H15NO3
Molecular Weight 173.210
Flash Point 107.2±25.4 °C
Exact Mass 173.105194
PSA 49.77000
LogP -0.17
Vapour Pressure 0.0±1.1 mmHg at 25°C
Index of Refraction 1.511
Storage condition 2-8°C
Symbol GHS05 GHS07
GHS05, GHS07
Signal Word Danger
Hazard Statements H302-H315-H318-H335
Precautionary Statements P261-P280-P305 + P351 + P338
Personal Protective Equipment dust mask type N95 (US);Eyeshields;Gloves
Hazard Codes Xi,Xn
Risk Phrases R36/37/38
Safety Phrases S26-S36/37/39
RIDADR NONH for all modes of transport
HS Code 2933990090
HS Code 2933990090
Summary 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.